ZYXI Zynex, Inc. Common Stock aka ZYXI

ZYXI Current Situation

  • Hold cash

ZYXI Plot with Buy and Sell Trade Signals

  • ZYXI open price graphed for rolling 12 months
    • Rolling 12 month plot starts on 2019-09-19
    • Rolling 12 month only includes complete buy sell pairs
  • Buy is marked with an X
  • Sell is marked with an octagon
  • Trades are executed at market open
  • A buy and a sell resulting in a gain is highlighted in green
  • A buy and a sell resulting in a loss is highlighted in red
  • Click graph below to enlarge it


Adjusted Open Plot for 
ZYXI
Zynex, Inc. Common Stock
 (ZYXI)

Cumulative Trading Results for 
ZYXI
Zynex, Inc. Common Stock
 (ZYXI)

Cumulative Benchmark Buy and Hold Results for 
ZYXI
Zynex, Inc. Common Stock
 (ZYXI)

ZYXI Trading Results

Total Percentage Period
-8.64 3 Months
21.48 6 Months
43.00 9 Months
23.10 YTD Months
12.54 12 Months
126.26 24 Months
125.28 All Months

Trade Assumptions

  • Results are added up to calculate total % change
  • Results don’t account for compounding of % gains
  • Results that are positive are gains
  • Results that are negative are losses
  • Results don’t include incomplete buy/sell pairs (e.g. a buy without a sell)
  • Results don’t account for dividends, even if dividend payment is applicable
  • Results include a commission of $0.029 per share for both buys and sells
  • You will need to account for your broker’s specific commission costs
  • Results may be impacted by inaccurate or incomplete data
  • Results are only for educational and informational use
  • Results don’t account for taxes
  • You will need to consult a tax professional
  • Buy and hold strategy for ZYXI was used as the benchmark

Viemed Healthcare, Inc. Common Shares aka VMD

VMD Current Situation

  • Hold stock

VMD Plot with Buy and Sell Trade Signals

  • VMD open price graphed for rolling 12 months
    • Rolling 12 month plot starts on 2019-09-19
    • Rolling 12 month only includes complete buy sell pairs
  • Buy is marked with an X
  • Sell is marked with an octagon
  • Trades are executed at market open
  • A buy and a sell resulting in a gain is highlighted in green
  • A buy and a sell resulting in a loss is highlighted in red
  • Click graph below to enlarge it


Adjusted Open Plot for Viemed Healthcare, Inc. Common Shares (VMD)

Cumulative Trading Results for Viemed Healthcare, Inc. Common Shares (VMD)

Cumulative Benchmark Buy and Hold Results for Viemed Healthcare, Inc. Common Shares (VMD)

VMD Trading Results

Total Percentage Period
-33.76 3 Months
11.28 6 Months
0.73 9 Months
0.26 YTD Months
2.42 12 Months
8.57 24 Months
8.57 All Months

Trade Assumptions

  • Results are added up to calculate total % change
  • Results don’t account for compounding of % gains
  • Results that are positive are gains
  • Results that are negative are losses
  • Results don’t include incomplete buy/sell pairs (e.g. a buy without a sell)
  • Results don’t account for dividends, even if dividend payment is applicable
  • Results include a commission of $0.029 per share for both buys and sells
  • You will need to account for your broker’s specific commission costs
  • Results may be impacted by inaccurate or incomplete data
  • Results are only for educational and informational use
  • Results don’t account for taxes
  • You will need to consult a tax professional
  • Buy and hold strategy for VMD was used as the benchmark

Vir Biotechnology, Inc. aka VIR

VIR Current Situation

  • Hold stock

VIR Plot with Buy and Sell Trade Signals

  • VIR open price graphed for rolling 12 months
    • Rolling 12 month plot starts on 2019-09-19
    • Rolling 12 month only includes complete buy sell pairs
  • Buy is marked with an X
  • Sell is marked with an octagon
  • Trades are executed at market open
  • A buy and a sell resulting in a gain is highlighted in green
  • A buy and a sell resulting in a loss is highlighted in red
  • Click graph below to enlarge it


Adjusted Open Plot for Vir Biotechnology, Inc.  (VIR)

Cumulative Trading Results for Vir Biotechnology, Inc.  (VIR)

Cumulative Benchmark Buy and Hold Results for Vir Biotechnology, Inc.  (VIR)

VIR Trading Results

Total Percentage Period
-8.71 3 Months
-8.18 6 Months
75.03 9 Months
75.03 YTD Months
75.03 12 Months
75.03 24 Months
75.03 All Months

Trade Assumptions

  • Results are added up to calculate total % change
  • Results don’t account for compounding of % gains
  • Results that are positive are gains
  • Results that are negative are losses
  • Results don’t include incomplete buy/sell pairs (e.g. a buy without a sell)
  • Results don’t account for dividends, even if dividend payment is applicable
  • Results include a commission of $0.029 per share for both buys and sells
  • You will need to account for your broker’s specific commission costs
  • Results may be impacted by inaccurate or incomplete data
  • Results are only for educational and informational use
  • Results don’t account for taxes
  • You will need to consult a tax professional
  • Buy and hold strategy for VIR was used as the benchmark

TWOU 2U, Inc. Common Stock aka TWOU

TWOU Current Situation

  • Hold cash

TWOU Plot with Buy and Sell Trade Signals

  • TWOU open price graphed for rolling 12 months
    • Rolling 12 month plot starts on 2019-09-19
    • Rolling 12 month only includes complete buy sell pairs
  • Buy is marked with an X
  • Sell is marked with an octagon
  • Trades are executed at market open
  • A buy and a sell resulting in a gain is highlighted in green
  • A buy and a sell resulting in a loss is highlighted in red
  • Click graph below to enlarge it


Adjusted Open Plot for 
TWOU
2U, Inc. Common Stock
 (TWOU)

Cumulative Trading Results for 
TWOU
2U, Inc. Common Stock
 (TWOU)

Cumulative Benchmark Buy and Hold Results for 
TWOU
2U, Inc. Common Stock
 (TWOU)

TWOU Trading Results

Total Percentage Period
-17.90 3 Months
28.32 6 Months
35.12 9 Months
35.12 YTD Months
40.60 12 Months
24.18 24 Months
65.78 All Months

Trade Assumptions

  • Results are added up to calculate total % change
  • Results don’t account for compounding of % gains
  • Results that are positive are gains
  • Results that are negative are losses
  • Results don’t include incomplete buy/sell pairs (e.g. a buy without a sell)
  • Results don’t account for dividends, even if dividend payment is applicable
  • Results include a commission of $0.029 per share for both buys and sells
  • You will need to account for your broker’s specific commission costs
  • Results may be impacted by inaccurate or incomplete data
  • Results are only for educational and informational use
  • Results don’t account for taxes
  • You will need to consult a tax professional
  • Buy and hold strategy for TWOU was used as the benchmark

Translate Bio, Inc. (TBIO) aka TBIO

TBIO Current Situation

  • Hold stock

TBIO Plot with Buy and Sell Trade Signals

  • TBIO open price graphed for rolling 12 months
    • Rolling 12 month plot starts on 2019-09-19
    • Rolling 12 month only includes complete buy sell pairs
  • Buy is marked with an X
  • Sell is marked with an octagon
  • Trades are executed at market open
  • A buy and a sell resulting in a gain is highlighted in green
  • A buy and a sell resulting in a loss is highlighted in red
  • Click graph below to enlarge it


Adjusted Open Plot for Translate Bio, Inc.  (TBIO) (TBIO)

Cumulative Trading Results for Translate Bio, Inc.  (TBIO) (TBIO)

Cumulative Benchmark Buy and Hold Results for Translate Bio, Inc.  (TBIO) (TBIO)

TBIO Trading Results

Total Percentage Period
-13.71 3 Months
24.54 6 Months
22.25 9 Months
30.60 YTD Months
23.10 12 Months
119.98 24 Months
119.98 All Months

Trade Assumptions

  • Results are added up to calculate total % change
  • Results don’t account for compounding of % gains
  • Results that are positive are gains
  • Results that are negative are losses
  • Results don’t include incomplete buy/sell pairs (e.g. a buy without a sell)
  • Results don’t account for dividends, even if dividend payment is applicable
  • Results include a commission of $0.029 per share for both buys and sells
  • You will need to account for your broker’s specific commission costs
  • Results may be impacted by inaccurate or incomplete data
  • Results are only for educational and informational use
  • Results don’t account for taxes
  • You will need to consult a tax professional
  • Buy and hold strategy for TBIO was used as the benchmark